Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
American Thoracic Society
2018
|